Det er et stort udekket behov for slankepreparater uten bivirkninger. Novo Nordisk har frem til november 2023 vært det eneste selskapet som har hatt godkjente preparater på markedet for behandling av overvektige: Saxenda og Wegowy. Begge disse preparatene tilhører gruppen av hormoner kjent som GLP-1.
We conclude that equity investors may suffer during times of high inflation but in recent history, equities have indeed worked as a hedge against inflation.
Our recent visit to Indonesia left us pleasantly surprised by the remarkable economic developments taking place in the country.
There are good reasons for excitement, but a grain of realism is needed not expecting AI to solve all world problems. We are following the AI revolution which will probably be more of an evolutionary process.
Jim Hagemann Snabe, Chair of the Supervisory Board of Siemens AG, Chair of the Board of Directors of Northvolt and Member of the Board of C3 AI, shares his views of the 2020's from a leadership perspective.
